Cargando…
Highly active engineered IgG3 antibodies against SARS-CoV-2
Monoclonal antibodies (mAbs) that efficiently neutralize SARS-CoV-2 have been developed at an unprecedented speed. Notwithstanding, there is a vague understanding of the various Ab functions induced beyond antigen binding by the heavy-chain constant domain. To explore the diverse roles of Abs in SAR...
Autores principales: | Kallolimath, Somanath, Sun, Lin, Palt, Roman, Stiasny, Karin, Mayrhofer, Patrick, Gruber, Clemens, Kogelmann, Benjamin, Chen, Qiang, Steinkellner, Herta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545452/ https://www.ncbi.nlm.nih.gov/pubmed/34599091 http://dx.doi.org/10.1073/pnas.2107249118 |
Ejemplares similares
-
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
por: Sun, Lin, et al.
Publicado: (2021) -
Expression Profiling and Glycan Engineering of IgG Subclass 1–4 in Nicotiana benthamiana
por: Kallolimath, Somanath, et al.
Publicado: (2020) -
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
por: Kallolimath, Somanath, et al.
Publicado: (2023) -
Reply to Pandey: Possible functional impact of IgG3 allotype constant region
por: Kallolimath, Somanath, et al.
Publicado: (2022) -
In planta expression of active bacterial GDP‐6‐deoxy‐d‐lyxo‐4‐hexulose reductase for glycan modulation
por: Kogelmann, Benjamin, et al.
Publicado: (2023)